D.E. Shaw & Co
ACLX

D.E. Shaw & Co’s Arcellx ACLX Stock Holding History

D.E. Shaw & Co’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,165
Closed -$1.64M – 4476
2025
Q4 		$1.64M Buy
+25,165
New +$2.01M ﹤0.01% 3207
2024
Q4 		– Sell
-6,305
Closed -$527K – 4356
2024
Q3 		$527K Buy
+6,305
New +$420K ﹤0.01% 3668
2024
Q2 		– Sell
-25,286
Closed -$1.76M – 4441
2024
Q1 		$1.76M Sell
25,286
-41,788
-62% -$2.65M ﹤0.01% 2732
2023
Q4 		$3.72M Buy
+67,074
New +$3.03M ﹤0.01% 2154
2023
Q3 		– Sell
-20,210
Closed -$639K – 4220
2023
Q2 		$639K Buy
+20,210
New +$773K ﹤0.01% 3315
2023
Q1 		– Sell
-78,725
Closed -$2.44M – 4384
2022
Q4 		$2.44M Buy
+78,725
New +$1.81M ﹤0.01% 2775

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

D.E. Shaw & Co's ACLX Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 25,165 shares — an estimated $1.64M sold.

D.E. Shaw & Co first reported a position in ACLX in Q4 2022 and held it in 6 quarters. The position peaked at $3.72M in Q4 2023. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 25,165 Arcellx shares in Q1 2026, an estimated $1.64M.
  • D.E. Shaw & Co first reported a position in Arcellx in Q4 2022 and held it in 6 quarters.
  • D.E. Shaw & Co's Arcellx position peaked at $3.72M in Q4 2023.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.